Prenetics Global Limited has announced a significant leadership change with the appointment of Brian J. Rosin as the new Chief Financial Officer (CFO), effective December 31, 2026. Rosin will succeed Stephen Lo, who has served as CFO through a transformative period for the company. This transition is critical as Prenetics focuses on its flagship brand, IM8, which has become a major revenue generator.

The announcement was made on November 3, 2026, and is part of a planned transition that began when Rosin joined the company as CFO of IM8 in May 2026. His appointment is expected to streamline the company’s finance operations, consolidating leadership under a single CFO as IM8 now represents nearly all of Prenetics’ revenue.

Background

Prenetics Global Ltd, trading under the ticker symbols PRE and PRENW on the Nasdaq, is classified under the SIC code 2834, which pertains to Pharmaceutical Preparations. The company is known for its innovative health and longevity products, particularly through its IM8 brand, co-founded with David Beckham. Recent filings indicate a series of strategic updates, including financial reports and leadership changes, aimed at enhancing its market position.

What the Filing Says

The filing indicates, “On November 3, 2026, Prenetics Global Limited announced that Brian J. Rosin will succeed Stephen Hoi Chun Lo as Chief Financial Officer.” It further notes that Rosin will serve as CFO-designate until the end of the year, working alongside Lo for a smooth transition.

Impact

This leadership change may impact various stakeholders, including investors, employees, and customers. Rosin's experience in finance leadership, particularly in the consumer health sector, positions him to enhance Prenetics' financial strategies and investor relations. The focus on a U.S.-based finance leadership aligns with the company's growth strategy in its largest market.

What's Next

The Board of Directors is expected to formalize Rosin's appointment at its meeting on November 12, 2026. Additionally, Prenetics will report its third-quarter financial results on November 18, 2026, during a live-streamed earnings event, where management will discuss the results and engage with investors.